natgillin/translations-raw huggingface dataset:
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on formetanate, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 29 September 2006 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za formetanat, in zlasti dodatkov I in II k poročilu, kakor je bilo dokončno oblikovano v Stalnem odboru za prehranjevalno verigo in zdravje živali 29. septembra 2006.
must pay particular attention to the protection of birds, mammals, non-target arthropods and bees and must ensure that the conditions of authorisation include, where appropriate, risk mitigation measures;
biti zlasti pozorne na zaščito ptic, sesalcev, neciljnih členonožcev in čebel ter zagotoviti, da pogoji registracije po potrebi vključujejo ukrepe za zmanjšanje tveganja,
must pay particular attention to the operator safety and ensure that conditions of use prescribe the application of adequate personal protective equipment;
biti zlasti pozorne na varnost uporabnikov ter zagotoviti, da je v pogojih uporabe predpisana uporaba ustrezne osebne zaščitne opreme,
must pay particular attention to the dietary exposure of consumers in view of future revisions of Maximum Residue Levels.
biti zlasti pozorne na izpostavljenost uporabnikov prek vnosa hrane v okviru prihodnjih revizij mejnih vrednosti ostankov.
The Member States concerned shall request the submission of further studies to confirm the risk assessment for birds, mammals and non-target arthropods.
Zadevne države članice zahtevajo predložitev nadaljnjih študij za potrditev ocene tveganja za ptice, sesalce in neciljne členonožce.
They shall ensure that the notifier at whose request formetanate has been included in this Annex provide such studies to the Commission within two years from the entry into force of this Directive.
Zadevne države članice zagotovijo, da prijavitelj, na zahtevo katerega je bil formetanat vključen v to prilogo, takšne študije predloži Komisiji v roku dveh let od začetka veljavnosti te direktive.
CAS No 2032-65-7
št. CAS 2032-65-7
CIPAC No 165
št. CIPAC 165
4-methylthio-3,5-xylyl methylcarbamate
4-metiltio-3,5-ksilil metilkarbamat
Only uses as repellent in seed treatment, insecticide and molluscicide may be authorised.
Registrira se lahko samo kot repelent pri obdelavi semen, kot insekticid in moluskicid.
In assessing applications to authorise plant protection products containing methiocarb for uses other than seed treatment in maize Member States shall pay particular attention to the criteria in Article 4(1)(b), and shall ensure that any necessary data and information is provided before such an authorisation is granted.
Pri ocenjevanju vlog za registracijo fitofarmacevtskih sredstev, ki vsebujejo metiokarb, za druge načine uporabe kot za obdelavo koruznih semen, so države članice zlasti pozorne na merila iz člena 4(1)(b) in zagotovijo, da se pred odobritvijo takšne registracije predložijo vsi potrebni podatki in informacije.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on methiocarb, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 29 September 2006 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za metiokarb, in zlasti dodatkov I in II k poročilu, kakor je bilo dokončno oblikovano v Stalnem odboru za prehranjevalno verigo in zdravje živali 29. septembra 2006.
must pay particular attention to the protection of birds, mammals and non-target arthropods and must ensure that the conditions of authorisation include, where appropriate, risk mitigation measures;
biti zlasti pozorne na zaščito ptic, sesalcev in neciljnih členonožcev ter zagotoviti, da pogoji registracije po potrebi vključujejo ukrepe za zmanjšanje tveganja,
must pay particular attention to the operator and bystander safety and ensure that conditions of use prescribe the application of adequate personal protective equipment;
biti zlasti pozorne na varnost uporabnikov in drugih prisotnih oseb ter zagotoviti, da je v pogojih uporabe predpisana uporaba ustrezne osebne zaščitne opreme,
The Member States concerned shall request the submission of further studies to confirm the risk assessment for birds, mammals and non-target arthropods, as well as to confirm the toxicological assessment on metabolites potentially present in crops.
Zadevne države članice zahtevajo predložitev nadaljnjih študij za potrditev dolgoročne ocene tveganja za ptice, sesalce in neciljne členonožce ter za potrditev toksikološke ocene metabolitov, ki bi lahko bili prisotni v pridelkih.
They shall ensure that the notifier at whose request methiocarb has been included in this Annex provide such studies to the Commission within two years from the entry into force of this Directive.’
Zadevne države članice zagotovijo, da prijavitelj, na zahtevo katerega je bil metiokarb vključen v to prilogo, takšne študije predloži Komisiji v roku dveh let od začetka veljavnosti te direktive.“
Commission Directive 2007/6/EC
Direktiva Komisije 2007/6/ES
amending Council Directive 91/414/EEC to include metrafenone, Bacillus subtilis, spinosad and thiamethoxam as active substances
o spremembi Direktive Sveta 91/414/EGS zaradi vključitve metrafenona, Bacillus subtilis, spinosada in tiametoksama med aktivne snovi
In accordance with Article 6(2) of Directive 91/414/EEC United Kingdom received on 4 June 2002 an application from BASF AG, Belgium for the inclusion of the active substance metrafenone in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Združeno kraljestvo 4. junija 2002 prejelo zahtevek podjetja BASF AG, Belgija za vključitev aktivne snovi metrafenon v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2003/105/EC [2] confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Komisija je z Odločbo 2003/105/ES [2] potrdila, da je dokumentacija „popolna“ v smislu načelnega izpolnjevanja zahtev po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
In accordance with Article 6(2) of Directive 91/414/EEC Germany received on 19 April 2000 an application from AgraQuest for the inclusion of the active substance Bacillus subtilis strain QST 713 (hereafter Bacillus subtilis) in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Nemčija 19. aprila 2000 prejela zahtevek podjetja AgraQuest za vključitev seva QST 713 Bacillus subtilis (v nadaljevanju „Bacillus subtilis“) kot aktivne snovi v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2001/6/EC [3] confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Komisija je z Odločbo 2001/6/ES [3] potrdila, da je dokumentacija „popolna“ v smislu načelnega izpolnjevanja zahtev po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
In accordance with Article 6(2) of Directive 91/414/EEC the Netherlands received on 19 July 1999 an application from Dow AgroSciences for the inclusion of the active substance spinosad in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Nizozemska 19. julija 1999 prejela zahtevek podjetja Dow AgroSciences za vključitev aktivne snovi spinosad v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2000/210/EC [4] confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Komisija je z Odločbo 2000/210/ES [4] potrdila, da je dokumentacija „popolna“ v smislu načelnega izpolnjevanja zahtev po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
In accordance with Article 6(2) of Directive 91/414/EEC Spain received on 17 March 1999 an application from Novartis Crop Protection AG (now Syngenta) for the inclusion of the active substance thiamethoxam in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Španija 17. marca 1999 prejela zahtevek podjetja Novartis Crop Protection AG (zdaj Syngenta) za vključitev aktivne snovi tiametoksam v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2000/181/EC [5] confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Komisija je z Odločbo 2000/181/ES [5] potrdila, da je dokumentacija „popolna“ v smislu načelnega izpolnjevanja zahtev po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
For those active substances, the effects on human health and the environment have been assessed, in accordance with the provisions of Article 6(2) and (4) of Directive 91/414/EEC, for the uses proposed by the applicants.
Za navedene aktivne snovi so bili ocenjeni vplivi na zdravje ljudi in na okolje v skladu z določbami člena 6(2) in (4) Direktive 91/414/EGS za vrste uporab, ki so jih predlagali vlagatelji.
The designated rapporteur Member States submitted draft assessment reports concerning the substances to the European Food Safety Authority (EFSA) on 31 October 2003 (metrafenone) and to the Commission on 15 May 2001 (Bacillus subtilis), 5 March 2001 (spinosad) and 21 January 2002 (thiamethoxam) respectively.
Država članica, ki je bila določena za poročanje, je Evropski agenciji za varnost hrane (EFSA) predložila osnutke poročil o oceni snovi, in sicer 31. oktobra 2003 za metrafenon, Komisiji pa 15. maja 2001 za Bacillus subtilis, 5. marca 2001 (spinosad) ter 21. januarja 2002 za tiametoksam.
For Bacillus subtilis, spinosad and thiamethoxam the draft assessment reports have been reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health.
Osnutke poročil o oceni snovi Bacillus subtilis, spinosad in tiametoksam so pregledale države članice in Komisija v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali.
The review was finalised on 14 July 2006 in the format of the Commission review reports for metrafenone, Bacillus subtilis, spinosad and thiamethoxam.
Strokovni pregled je bil dokončan 14. julija 2006 v obliki poročil Komisije za snovi metrafenon, Bacillus subtilis, spinosad in tiametoksam.
It has appeared from the various examinations made that plant protection products containing the active substances concerned may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) and Article 5(3) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Različne preiskave, ki so bile opravljene, so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo katero koli od zadevnih aktivnih snovi, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) ter člena 5(3) Direktive 91/414/EGS, zlasti glede vrst uporabe, ki so bile preučene in podrobno navedene v poročilih Komisije o pregledu.
It is therefore appropriate to include metrafenone, Bacillus subtilis, spinosad and thiamethoxam in Annex I to that Directive, in order to ensure that in all Member States the authorisations of plant protection products containing these active substances may be granted in accordance with the provisions of that Directive.
Zato je primerno vključiti metrafenon, Bacillus subtilis, spinosad in tiametoksam v Prilogo I k navedeni direktivi, da se lahko v vseh državah članicah izdajo registracije za fitofarmacevtska sredstva, ki vsebujejo te aktivne snovi, v skladu z določbami navedene direktive.
Without prejudice to the obligations defined by Directive 91/414/EEC as a consequence of including an active substance in Annex I, Member States should be allowed a period of six months after inclusion to review existing provisional authorisations of plant protection products containing metrafenone, Bacillus subtilis, spinosad or thiamethoxam to ensure that the requirements laid down by Directive 91/414/EEC, in particular in its Article 13 and the relevant conditions set out in Annex I, are satisfied. Member States should transform existing provisional authorisations into full authorisations, amend them or withdraw them in accordance with the provisions of Directive 91/414/EEC.
Brez poseganja v obveznosti, opredeljene v Direktivi 91/414/EGS kot posledica vključitve aktivne snovi v Prilogo I, je treba dovoliti državam članicam, da v šestih mesecih po vključitvi pregledajo obstoječe začasne registracije fitofarmacevtskih sredstev, ki vsebujejo metrafenon, Bacillus subtilis, spinosad ali tiametoksam, da se zagotovi izpolnjevanje zahtev iz Direktive 91/414/EGS, zlasti iz člena 13, in ustreznih pogojev iz Priloge I. Države članice morajo preoblikovati obstoječe začasne registracije v dokončne registracije, jih spremeniti ali preklicati v skladu z določbami Direktive 91/414/EGS.
By derogation from the above deadline, a longer period should be provided for the submission and assessment of the complete Annex III dossier of each plant protection product for each intended use in accordance with the uniform principles laid down in Directive 91/414/EEC.
Z odstopanjem od zgoraj določenega roka je treba določiti daljše obdobje za predložitev in oceno celotne dokumentacije iz Priloge III o vsakem fitofarmacevtskem sredstvu za vsako predvideno uporabo v skladu z enotnimi načeli iz Direktive 91/414/EGS.
They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
Komisiji nemudoma predložijo besedila navedenih predpisov in primerjalno razpredelnico med navedenimi predpisi in to direktivo.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing metrafenone, Bacillus subtilis, spinosad or thiamethoxam as active substance by 31 July 2007.
Države članice do 31. julija 2007 v skladu z Direktivo 91/414/EGS po potrebi spremenijo ali prekličejo obstoječe registracije za fitofarmacevtska sredstva, ki vsebujejo aktivne snovi metrafenon, Bacillus subtilis, spinosad ali tiametoksam.
By that date, they shall in particular verify that the conditions in Annex I to that Directive relating to metrafenone, Bacillus subtilis, spinosad or thiamethoxam, respectively, are met, with the exception of those identified in part B of the entry concerning the active substance, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13(2).
Do tega datuma zlasti preverijo, da so pogoji iz Priloge I k navedeni direktivi v zvezi s snovmi metrafenon, Bacillus subtilis, spinosad ali tiametoksam izpolnjeni, razen tistih, ki so opredeljeni v delu B uvrstitve navedenih aktivnih snovi, in da ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni Direktivi v skladu s pogoji iz člena 13(2).
By way of derogation from paragraph 1, for each authorised plant protection product containing metrafenone or Bacillus subtilis or spinosad or thiamethoxam as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 31 January 2007 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning metrafenone, Bacillus subtilis, spinosad or thiamethoxam.
Z odstopanjem od odstavka 1 države članice ponovno ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje metrafenon, Bacillus subtilis, spinosad ali tiametoksam, bodisi kot edino aktivno snov bodisi kot eno od več aktivnih snovi, ki so bile uvrščene v Prilogo I k Direktivi 91/414/EGS najpozneje do 31. januarja 2007, ter v skladu z enotnimi načeli iz Priloge VI k Direktivi 91/414/EGS, in sicer na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k navedeni direktivi, in ob upoštevanju dela B uvrstitve v Prilogi I k navedeni direktivi glede snovi metrafenon, Bacillus subtilis, spinosad ali tiametoksam.
in the case of a product containing metrafenone or Bacillus subtilis or spinosad or thiamethoxam as the only active substance, where necessary, amend or withdraw the authorisation by 31 July 2008 at the latest; or
po potrebi spremenijo ali prekličejo registracijo najpozneje do 31. julija 2008, če fitofarmacevtsko sredstvo vsebuje metrafenon ali Bacillus subtilis ali spinosad ali tiametoksam kot edino aktivno snov; ali
in the case of a product containing metrafenone or Bacillus subtilis or spinosad or thiamethoxam as one of several active substances, where necessary, amend or withdraw the authorisation by 31 July 2008 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
če fitofarmacevtsko sredstvo vsebuje metrafenon ali Bacillus subtilis ali spinosad ali tiametoksam kot eno od več aktivnih snovi, po potrebi spremenijo ali prekličejo registracijo najpozneje do 31. julija 2008 ali do datuma, določenega za tako spremembo ali preklic registracije v ustrezni direktivi ali direktivah, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS, pri čemer se upošteva poznejši datum.
OJ L 2, 5.1.2001, p. 25.
UL L 2, 5.1.2001, str. 25.
EFSA Scientific Report (2006)58, 1-72, Conclusion regarding the peer review of the pesticide risk assessment of the active substance metrafenone (finalised: 13 January 2006).
Znanstveno poročilo EFSA (2006) 58, 1–72, Sklep o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo metrafenon (dokončano: 13. januarja 2006).
The following rows shall be added at the end of the table in Annex I to Directive 91/414/EEC:
Naslednje vrstice naj se dodajo na konec razpredelnice v Prilogi I k Direktivi 91/414/EGS:
CAS No: 220899-03-6
Št. CAS: 220899-03-6
CIPAC No: 752
Št. CIPAC: 752
3′-bromo-2,3,4,6′-tetramethoxy-2′,6-dimethylbenzophenone
3′-bromo-2,3,4,6′-tetrametoksi-2′,6-dimetilbenzofenon
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on metrafenone, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 14 July 2006 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za metrafenon in zlasti dodatkov I in II k poročilu, kot je bilo dokončno oblikovano v Stalnem odboru za prehranjevalno verigo in zdravje živali 14. julija 2006.
Strain QST 713, identical with strain AQ 713
Sev QST 713, identičen s sevom AQ 713
Culture collection No: NRRL B -21661
zbirka kultur št.: NRRL B -21661
CIPAC No: not allocated
Št. CIPAC: ni dodeljena
Not applicable
Se ne uporablja.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on Bacillus subtilis, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 14 July 2006 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za Bacillus subtilis, in zlasti dodatkov I in II k poročilu, kot je bilo dokončno oblikovano v Stalnem odboru za prehranjevalno verigo in zdravje živali 14. julija 2006.
CAS No: 131929-60-7 (Spinosyn A)
Št. CAS: 131929-60-7 (spinosin A)
CIPAC No: 636
Št. CIPAC: 636
(2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-ß-D-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione
(2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoksi-2,3,4-tri-O-metil-α-L-manopiranosiloksi)-13-(4-dimetilamino-2,3,4,6-tetradeoksi-ß-D-eritropiranosiloksi)-9-etil-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-heksadekahidro-14-metil-1H-8-oksaciklododeka[b]as-indacen-7,15-dion
(2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-ß-D-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione
(2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoksi-2,3,4-tri-O-metil-α-L-manopiranosiloksi)-13-(4-dimetilamino-2,3,4,6-tetradeoksi-ß-D-eritropiranosiloksi)-9-etil-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-heksadekahidro-4,14-dimetil-1H-8-oksaciklododeka[b]as-indacen-7,15-dion
Spinosad is a mixture of 50-95 % spinosyn A and 5-50 % spinosyn D
Spinosad je sestavljen iz 50–95 % spinosina A in 5–50 % spinosina D.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on spinosad, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 14 July 2006 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za spinosad in zlasti dodatkov I in II k poročilu, kot je bilo dokončno oblikovano v Stalnem odboru za prehranjevalno verigo in zdravje živali 14. julija 2006.
must pay particular attention to the protection of aquatic organisms;
nameniti posebno pozornost zaščiti vodnih organizmov,
must pay particular attention to the risk to earthworms when the substance is used in glasshouses.
nameniti posebno pozornost tveganju za deževnike, če se snov uporablja v rastlinjakih.
CAS No: 153719-23-4
Št. CAS: 153719-23-4
CIPAC No: 637
Št. CIPAC: 637
(E,Z)-3-(2-chloro-thiazol-5-ylmethyl)-5-methyl-[1,3,5]oxadiazinan-4-ylidene-N-nitroamine
(E,Z)-3-(2-kloro-tiazol-5-ilmetil)-5-metil-[1,3,5]oksadiazinan-4-iliden-N-nitroamin
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on thiamethoxam, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 14 July 2006 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za tiametoksam in zlasti dodatkov I in II k poročilu, kot je bilo dokončno oblikovano v Stalnem odboru za prehranjevalno verigo in zdravje živali 14. julija 2006.
must pay particular attention to the potential for groundwater contamination, particularly of the active substance and its metabolites NOA 459602, SYN 501406 and CGA 322704, when the active substance is applied in regions with vulnerable soil and/or climatic conditions,
nameniti posebno pozornost možnemu onesnaženju podtalnice, zlasti z aktivnimi snovi in njihovimi metaboliti NOA 459602, SYN 501406 in CGA 322704, če se aktivna snov uporablja na območjih, kjer so občutljiva tla in/ali podnebni pogoji,
must pay particular attention to the protection of aquatic organisms,
nameniti posebno pozornost zaščiti vodnih organizmov,
must pay particular attention to the long-term risk to small herbivorous animals if the substance is used for seed treatment.
nameniti posebno pozornost dolgoročnemu tveganju za male rastlinojede živali, če se snov uporablja za obdelavo semen.
Conditions of use shall include risk mitigation measures, where appropriate.’
Pogoji uporabe morajo po potrebi vključevati ukrepe za zmanjšanje tveganja.“
131929-63-0 (Spinosyn D)
131929-63-0 (spinosin D)
Spinosyn A:
Spinosin A:
Spinosyn D:
Spinosin D: